HomeBusiness NewsHealthy Returns: Biotech IPOs ramped up to start 2024, but the market...

Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn’t fully recovered just yet

- Advertisement -spot_imgspot_img

Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills…

- Advertisement -spot_imgspot_img
Stay Connected
16,985FansLike
4,568FollowersFollow
Must Read
Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here